(June 28, 2024, 1:31 PM EDT) -- WASHINGTON, D.C. — OptumRx Inc. has agreed to pay $20 million to resolve claims that the prescription drug benefit provider improperly filled opioid prescriptions in violation of the Controlled Substances Act, the U.S. Department of Justice announced June 27....